Pandemic relief funds bolstered operating margins at vulnerable hospitals, Health Affairs finds

The funds have come under scrutiny, with some reports suggesting that high-performing hospitals capitalized on them to post record operating margins.

By Susanna Vogel • Aug. 23, 2023

Veradigm receives notice of delisting from Nasdaq

The health IT company, which is facing delisting after failing to file financial paperwork on time, plans to appeal the decision.

By Rebecca Pifer Parduhn • Updated Sept. 25, 2023

CVS layoffs hit Rhode Island, Connecticut, New York and more

The layoffs disclosed late last week to state labor departments include 770 employees in CVS’ Rhode Island headquarters, and about 520 workers at health insurer Aetna’s Connecticut hub.

By Rebecca Pifer Parduhn • Aug. 21, 2023

Babylon sells UK business as digital health company winds down operations

Babylon sold nearly all its U.K. assets to a U.S.-based company and appointed an administrator last week, after a take-private deal failed earlier in August.

By Emily Olsen • Updated Sept. 5, 2023

Mayo Clinic’s profit continued to rebound in the second quarter after 2022 struggles

The nonprofit posted sequential growth in profits in the second quarter, despite increasing expenses.

By Susanna Vogel • Aug. 18, 2023

A new threat to healthcare breakthroughs: litigation investment entities

Former HHS Secretary Tom Price identifies the dangers of litigation investment entities and their potential roadblocks to medical innovation.

By Tom Price • Aug. 18, 2023

Definitive Healthcare acquires data analytics startup Populi for $52M

The deal comes weeks after Definitive Healthcare announced layoffs.

By Emily Olsen • Aug. 15, 2023

Mass General Brigham posts positive operating margin in Q3 after high 2022 losses

The Boston-based health system posted an improvement in revenue and operating income after it was placed on a financial improvement plan by the state last year.

By Susanna Vogel • Aug. 15, 2023

PE healthcare deals dropped to years-low levels in Q2

The amount of private equity deals decreased 24% compared to the first quarter this year. However, deal volume was still higher than the average quarterly deal count pre-pandemic, according to a PitchBook report.

By Sydney Halleman • Aug. 14, 2023

5 predictions for private equity in healthcare

Grant Thornton principal Lisa Walkush explains why healthcare remains one of the most attractive options for private equity firms.

By Lisa Walkush • Aug. 11, 2023

Cano Health exploring sale, lays off 700 employees

The value-based primary care chain posted a net loss of $270.7 million in the second quarter, nearly 19 times larger than its loss in the prior-year period.

By Emily Olsen • Aug. 11, 2023

Doximity slashes 10% of workforce amid post-COVID pressures

CEO Jeff Tangney attributed the company’s slowdown to “post-COVID upsell weakness,” while also reducing Doximity’s revenue guidance.

By Brian T. Horowitz • Aug. 10, 2023

Healthcare M&A hit three-year low in Q2, report finds

Continuing financial pressures could keep deal-making low in the second half of the year, but M&A could heat up in early 2024, a new KPMG report finds.

By Emily Olsen • Aug. 10, 2023

For-profit hospitals beat Q2 expectations on rising admissions, expense improvements

Rebounding volume, including increased demand for elective surgeries, boosted toplines for HCA, Tenet, CHS and UHS in the second quarter.

By Susanna Vogel • Aug. 10, 2023

MA bonuses reach record high, with UnitedHealthcare, Humana biggest winners

Star ratings bonuses reached $12.8 billion, according to the KFF, as the Medicare program faces a growing spending crisis.

By Rebecca Pifer Parduhn • Aug. 10, 2023

Smaller insurers tout progress toward profitability in Q2

Clover notched its first quarterly adjusted EBITDA profit as a public company, while Oscar reached total company profitability for the second quarter in a row. Meanwhile, Bright posted its first quarter ever with positive adjusted EBITDA.

By Rebecca Pifer Parduhn • Aug. 9, 2023

5 takeaways from health insurers’ second-quarter earnings

UnitedHealth, CVS, Elevance and peers sidestepped the worst of medical cost growth in the quarter, but many payers face uncertainty from Medicare Advantage star ratings, GLP-1s and other pressures.

By Rebecca Pifer Parduhn • Aug. 8, 2023

Babylon’s take-private deal with MindMaze collapses

The digital health firm said it was exiting its core operations in the U.S. and searching for a buyer for its U.K. business. 

By Emily Olsen • Aug. 7, 2023

Kaiser Permanente in the black for second quarter, after loss in 2022

CFO Kathy Lancaster said Kaiser is ready to face the second half of the year after posting a $2.1 billion profit in the second quarter.

By Susanna Vogel • Aug. 7, 2023

Top paying specialties less likely to recruit women and underrepresented groups, study finds

The results suggest that lucrative specialties were less successful at recruiting underrepresented groups in medicine, according to a new JAMA study.

By Susanna Vogel • Aug. 4, 2023

Cigna checks medical cost growth as Evernorth earnings boosted by GLP-1s

Cigna’s medical costs in the quarter were “well-controlled,” one analyst said, but faced pressure from higher estimated risk-adjustment payments in the ACA individual exchanges.

By Rebecca Pifer Parduhn • Aug. 3, 2023

CHS announces new strategic initiatives to get back in black

After CHS posted a net income loss of $38 million on Wednesday, leadership told investors they have a plan to recover.

By Susanna Vogel • Aug. 3, 2023

Amwell lowers 2023 revenue outlook, racks up impairment charge in Q2

The telehealth company’s results are being impacted by churn on Amwell’s legacy platform as it migrates customers to its Converge software, CFO Robert Shepardson said.

By Emily Olsen • Aug. 3, 2023

CVS announces restructuring plan after profit falls 37%

CVS also lowered its 2024 earnings outlook, citing cost pressures, and said investors should no longer rely on its 2025 target.

By Rebecca Pifer Parduhn • Aug. 2, 2023

Humana reports lower-than-feared medical costs, raises MA membership growth outlook

Humana’s stock rose following the earnings, which — along with comments from other payers — suggest the uptick in outpatient care flagged earlier in the quarter is moderating.

By Rebecca Pifer Parduhn • Aug. 2, 2023